DiaMedica Therapeutics Inc To Discuss its ReMEDy2 Update Transcript
Good day, and welcome to DiaMedica Therapeutics ReMEDy2 Update Conference Call. (Operator Instructions) And finally, I would like to advise all participants this call is being recorded. Thank you.
I'd now like to hand over to Rick Pauls to begin the conference. Rick, over to you.
Good morning. Before we proceed with remarks, please note that we will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements.
More information, including factors that could cause actual results to differ from projected results, appears in the section entitled Cautionary Statement Note regarding forward-looking statements in the company's press release issued yesterday, and under the heading Risk Factors in DiaMedica's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. DiaMedica's SEC filings are available
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
